Clinical Trial Update: Tocilizumab for the Treatment of Familial Mediterranean Fever [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tocilizumab for Familial Mediterranean Fever has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Familial Mediterranean Fever | Phase 2 | Status: COMPLETED